Display options
Cite
DeHart A, Richter G. Hemangioma: Recent Advances. F1000Res. 2019;8doi: 10.12688/f1000research.20152.1.
DeHart, A., & Richter, G. (2019). Hemangioma: Recent Advances. F1000Research, 8. https://doi.org/10.12688/f1000research.20152.1
DeHart, Austin, and Richter, Gresham. "Hemangioma: Recent Advances." F1000Research vol. 8 (2019). doi: https://doi.org/10.12688/f1000research.20152.1
DeHart A, Richter G. Hemangioma: Recent Advances. F1000Res. 2019 Nov 18;8. doi: 10.12688/f1000research.20152.1. eCollection 2019. PMID: 31807282; PMCID: PMC6871355.
Copy Download .nbib Format: NLM
Share it on

F1000Res. 2019 Nov 18;8. doi: 10.12688/f1000research.20152.1. eCollection 2019.

Hemangioma: Recent Advances.

F1000Research

Austin DeHart, Gresham Richter

Affiliations

  1. Otolaryngology, Head and Neck Surgery, Arkansas Children's Hospital at the University of Arkansas for Medical Science, Little Rock, Arkansas, 72202, USA.

PMID: 31807282 PMCID: PMC6871355 DOI: 10.12688/f1000research.20152.1

Abstract

Hemangiomas are common benign vascular tumors that often present in childhood. Diagnosis is based on clinical history, physical examination, and, when unclear, assisted with ultrasound or MRI. While the majority are small, nonproblematic, and can be managed conservatively, some hemangiomas may be associated with underlying syndromes or concerning for visceral involvement. Symptomatic lesions may develop ulceration, bleeding, vision disturbances, functional limitations, or disfigurement. The ideal treatment for a symptomatic hemangioma is often multimodal and may vary depending on the size, location, and proximity to critical structures. Medical treatments include topical beta blockers, oral propranolol, or steroid injections. Surgical resection and laser therapies may be necessary to optimize long term outcomes.

Copyright: © 2019 DeHart A and Richter G.

Keywords: Hemangioma; vascular anomaly

Conflict of interest statement

No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.

References

  1. J Craniofac Surg. 2015 Jun;26(4):1169-72 - PubMed
  2. J Pediatr. 2014 Sep;165(3):634 - PubMed
  3. Laryngoscope. 2009 Nov;119(11):2242-7 - PubMed
  4. J Pediatr. 2010 Nov;157(5):795-801.e1-7 - PubMed
  5. Pediatrics. 2013 Jan;131(1):128-40 - PubMed
  6. BMJ Case Rep. 2013 Jul 31;2013: - PubMed
  7. Pediatr Dermatol. 2014 May-Jun;31(3):402-4 - PubMed
  8. J Pediatr. 2016 Nov;178:24-33.e2 - PubMed
  9. Pediatrics. 2016 Sep;138(3): - PubMed
  10. Lasers Surg Med. 2016 Mar;48(3):221-33 - PubMed
  11. Pediatr Dermatol. 2011 Nov-Dec;28(6):663-9 - PubMed
  12. Stroke. 2012 Jun;43(6):1672-4 - PubMed
  13. Pediatrics. 2016 Nov;138(5): - PubMed
  14. Pediatr Dermatol. 2015 Nov-Dec;32(6):808-12 - PubMed
  15. Pediatr Dermatol. 2011 May-Jun;28(3):245-53 - PubMed
  16. Int J Pediatr Otorhinolaryngol. 2017 Nov;102:61-66 - PubMed
  17. J Indian Assoc Pediatr Surg. 2019 Jul-Sep;24(3):170-175 - PubMed
  18. Pediatrics. 2015 Oct;136(4):e1060-104 - PubMed
  19. Pathol Res Pract. 2017 Jun;213(6):591-597 - PubMed
  20. Pediatr Radiol. 2005 Dec;35(12):1178-85 - PubMed
  21. Hum Pathol. 2000 Jan;31(1):11-22 - PubMed

MeSH terms

Publication Types